China's blue-chips, however, ended 0.2pc higher, helped by upbeat factory data which expanded for an eighth month in a row as an economic recovery gathered pace.
EMA said in early December it planned to decide on whether to approve the BioNTech/Pfizer vaccine by Dec 29, and another being developed by Moderna by Jan. 12.
Jordan's green light for the Pfizer vaccine follows those of Bahrain and Saudi Arabia and came six days after Britain launched the world's first mass innoculation campaign using the vaccine.
Berlin's irritation is more acute as BioNTech is a German firm and the country is preparing to go into partial lockdown from Wednesday, with non-essential shops and schools to close.
US top infectious disease expert Dr. Anthony Fauci told MSNBC on Monday that Americans with no heightened risk factors could expect to get vaccinated by late March or early April.
The broader-based S&P 500 was up by a similar amount, with markets also eyeing a $908 billion bipartisan stimulus plan set to be presented by lawmakers Monday.
But gold's losses were limited by hopes of further US fiscal stimulus, with Reuters reporting that a $908 billion relief plan will be split in two in an effort to win approval and could be introduced as early as Monday.
The doses will go to 14 sites around Canada, with the most vulnerable, including the elderly in long-term care facilities and healthcare workers, first in line for shots.
“We need to solve the manufacturing challenge,” Ugur Sahin told Reuters in an interview. “It is very clear that more doses are needed. And we are dealing with that question - how to produce more doses.”
The vaccine news helped offset fears from a sharp rise in coronavirus cases globally that has led to a string of renewed lockdowns, including strict measures in California, Germany and South Korea.
Doria has frequently clashed over the vaccine with Bolsonaro, an aggressive China critic who has baselessly dismissed the Sinovac candidate as lacking credibility.
Meanwhile, plans are reportedly being stepped up to ensure any complications arising from the end of the Brexit transition period on December 31 do not impact its roll-out.
In the first quarter of 2021, Oslo expects to receive a total of 2.5 million doses, covering 1.25 million people, pending approval of the vaccines from European regulators. Norway's population is 5.4 million.
Britain is the first Western country to approve a COVID-19 vaccine, a move that many see as a political coup for Prime Minister Boris Johnson's government.
Under EU rules, EMA recommends the authorisation of a drug or vaccine and the EU Commission authorizes them on the basis of the EMA's scientific advice.
The two vaccines have been developed at breathtaking speed as part of an unprecedented effort to end a pandemic that has infected more than 62 million people worldwide and killed more than 1.4 million.
Pfizer and German partner BioNTech SE confirmed a deal was forthcoming in a statement on Thursday but did not disclose financial details.
In televised remarks, Netanyahu said the agreement marked "a great day for Israel" and added: "The goal is for the vaccine supply to start in January and increase in the months thereafter".
Some Asian countries are prioritising containing the novel coronavirus rather than looking to stockpile vaccines, while others are looking for alternatives to the messenger RNA technology used by Pfizer that requires such ultra-cold storage.
Pfizer and German partner BioNTech SE are the first drugmakers to release successful data from a large-scale clinical trial of a coronavirus vaccine.
We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records,